Everhart Financial Group’s GT Biopharma GTBP Stock Holding History

Everhart Financial Group’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49K	Buy	+100,000	New	+$40.6K	﹤0.01%	477

Other funds holding GTBP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

4WM

49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return

Alongside Austin, Texas $525M AUM

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Everhart Financial Group's GTBP Position: Q2 2026 in Review

Everhart Financial Group opened a new position in GT Biopharma (GTBP) in Q2 2026: 100,000 shares worth $49K. The stake represents ﹤0.01% of the portfolio and ranks #477 among its holdings.

59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

Everhart Financial Group held 100,000 shares of GT Biopharma worth $49K as of Q2 2026.
GT Biopharma was a new Everhart Financial Group position in Q2 2026.
GT Biopharma made up ﹤0.01% of Everhart Financial Group's portfolio in Q2 2026, its #477 holding.
59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.